Stanford researchers identified pattern of gene expression shared by transplant patients who  stay healthy without anti-rejection drugs
| | | | | |

Stanford researchers identified pattern of gene expression shared by transplant patients who stay healthy without anti-rejection drugs

On Aug. 20, 2007, researchers from Stanford University announced they had identified a pattern of gene expression shared…

FDA approved trastuzumab for use with other drugs in adjuvant treatment of women with early-stage, node-positive, HER2-overexpressing breast cancer
| | | | | | |

FDA approved trastuzumab for use with other drugs in adjuvant treatment of women with early-stage, node-positive, HER2-overexpressing breast cancer

On Nov. 16, 2006, the U.S. Food and Drug Administration (FDA) approved Genentech’s trastuzumab (Herceptin) for use with…